KDEV.ST
Karolinska Development AB
Price:  
1.05 
SEK
Volume:  
522,046.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KDEV.ST Relative Valuation

-106.2%
Upside

As of 2024-12-14, the Relative Valuation of Karolinska Development AB (KDEV.ST) is (0.07) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 1.05 SEK, the upside of Karolinska Development AB based on Relative Valuation is -106.2%.

The range of the Relative Valuation is (0.30) - 0.44 SEK.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.2x - 30.5x 23.0x
Forward P/E multiples 21.6x - 27.4x 22.4x
Fair Price (0.30) - 0.44 (0.07)
Upside -128.5% - -58.6% -106.2%
1.05 SEK
Stock Price
(0.07) SEK
Fair Price

KDEV.ST Relative Valuation - Historical P/E Data

Date P/E
2024-12-11 -52.61
2024-12-10 -48.45
2024-12-09 -48.54
2024-12-06 -50.72
2024-12-05 -49.02
2024-12-04 -50.63
2024-12-03 -49.59
2024-12-02 -50.15
2024-11-29 -51.00
2024-11-28 -51.19
2024-11-27 -50.63
2024-11-26 -50.06
2024-11-25 -48.92
2024-11-22 -49.30
2024-11-21 -51.29
2024-11-20 -54.41
2024-11-19 -54.70
2024-11-18 -53.09
2024-11-15 -47.31
2024-11-14 -51.76
2024-11-13 -49.96
2024-11-12 -50.82
2024-11-11 -53.37
2024-11-08 -55.26
2024-11-07 -57.16
2024-11-06 -55.74
2024-11-05 -55.93
2024-11-04 -56.21
2024-11-01 -57.06
2024-10-31 -57.25
2024-10-30 -57.16
2024-10-29 -57.06
2024-10-28 -57.53
2024-10-25 -58.86
2024-10-24 -56.02
2024-10-23 -56.68
2024-10-22 -58.20
2024-10-21 -61.51
2024-10-18 -60.37
2024-10-17 -57.91
2024-10-16 -57.63
2024-10-15 -56.49
2024-10-14 -56.68
2024-10-11 -56.59
2024-10-10 -56.30
2024-10-09 -56.78
2024-10-08 -55.45
2024-10-07 -56.11
2024-10-04 -57.34
2024-10-03 -56.87